The effects of different electrolyte composition in dialysate on QTc interval; a controlled trial.
BACKGROUND
Hemodialysis (HD) has impact on the cardiovascular system by inducing changes in the characteristics of body fluids such as PH, temperature and electrolyte concentrations. In the previous studies, prolongation of the QT interval and increase of QT dispersion have been reported during HD sessions. These changes were more significant while using solutions with less potassium and higher bicarbonate during dialysis.


OBJECTIVE
The aim of our study was to investigate the effects of different potassium and bicarbonate concentrations on electrocardiography (ECG) parameters and the electrochemical balance of cell membranes.


METHODS
This is a double blind controlled clinical trial with crossover design. This interventional study has been conducted on 36 patients over 18 years who undergoing HD 3 times a week for at least 6 months. Twelve-lead ECG has been obtained before starting and one hour after end of each HD session. The QTc was measured and changes recorded by a cardiologist. Correlations were evaluated by univariate regression analysis.


RESULTS
54.38 years (16 to 77 years), 66.7% were male. No significant increase in QT interval has been seen while dialyzing with 2 meq/l potassium and 24 meq/l bicarbonate, 2 meq/l potassium and 28 meq/l bicarbonate and 3 meq/l potassium and 24 meq/l bicarbonate beside high calcium (2.5 meq/l) dialysate was conducted. Age, gender, serum calcium and serum bicarbonate level before HD session did not influence the mean QT intervals before and after dialysis.


CONCLUSIONS
Concentration of potassium beside moderate dose of bicarbonate in dialysis bath had not any significant influence on QT intervals after dialysis.
Department of Medicine, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran.
Foroogh
F
Sabzghabaei
Department of Medicine, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran.
Seyed Alireza
SA
Heydariezade
Department of Medicine, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran.
Rashin S
RS
Joodat
Cardiovascular disease; Dialysate fluid; Hemodialysis; QT interval
J Nephrol. 2012 Sep-Oct;25(5):653-60
21983985
Am J Kidney Dis. 2002 Apr;39(4):834-42
11920351
Postgrad Med J. 2002 May;78(919):273-5
12151568
Nephrol Dial Transplant. 2002 Dec;17(12):2170-7
12454229
Am J Kidney Dis. 1998 Nov;32(5 Suppl 3):S112-9
9820470
Caspian J Intern Med. 2013 Winter;4(1):590-4
24009942
Nephron. 1998;78(4):429-32
9578069
Am Heart J. 1996 Jun;131(6):1137-44
8644592
Nephrol Dial Transplant. 1998 Mar;13(3):668-73
9550645
J Hypertens. 2003 Oct;21(10):1921-6
14508199
Clin Auton Res. 2004 Aug;14 (4):233-9
15316840
Kidney Int. 2001 Jul;60(1):350-7
11422771
Clin Nephrol. 1998 Apr;49(4):240-4
9582555
Europace. 2008 Jun;10(6):771-7
18287086
Kidney Int. 2000 May;57(5):2117-22
10792632
J Am Soc Nephrol. 1999 Jan;10(1):160-3
9890322
Lancet. 1992 Jan 25;339(8787):212-3
1346174
J Am Soc Nephrol. 1999 Jun;10(6):1297-302
10361868
Nephrol Dial Transplant. 2005 Jun;20(6):1148-54
15784641
Nephrol Dial Transplant. 2000 Jun;15(6):765-8
10831625
Nephrol Dial Transplant. 1992;7(4):318-22
1317522
Physiol Rev. 2007 Apr;87(2):457-506
17429038